U.S. markets close in 1 hour 35 minutes

Allogene Therapeutics, Inc. (ALLO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
22.45+0.84 (+3.89%)
As of 2:25PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 7/27/2021
Current
3/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
3.07B4.96B3.54B5.25B5.94B
Enterprise Value 3
2.42B4.19B2.75B4.40B5.50B
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
71.40N/AN/AN/AN/A
Price/Book (mrq)
2.874.633.174.539.83
Enterprise Value/Revenue 3
63.20109.29N/AN/AN/A
Enterprise Value/EBITDA 7
-11.10-133.96-46.23-66.50-89.79

Trading Information

Stock Price History

Beta (5Y Monthly) 1.09
52-Week Change 3-42.74%
S&P500 52-Week Change 335.08%
52 Week High 344.92
52 Week Low 321.10
50-Day Moving Average 324.09
200-Day Moving Average 330.21

Share Statistics

Avg Vol (3 month) 31.36M
Avg Vol (10 day) 3501.8k
Shares Outstanding 5141.54M
Implied Shares Outstanding 6N/A
Float 73.9M
% Held by Insiders 134.88%
% Held by Institutions 162.99%
Shares Short (Jul 14, 2021) 49.48M
Short Ratio (Jul 14, 2021) 47.15
Short % of Float (Jul 14, 2021) 410.95%
Short % of Shares Outstanding (Jul 14, 2021) 46.70%
Shares Short (prior month Jun 14, 2021) 48.19M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-609.63%

Management Effectiveness

Return on Assets (ttm)-15.65%
Return on Equity (ttm)-27.29%

Income Statement

Revenue (ttm)38.34M
Revenue Per Share (ttm)0.30
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -226.45M
Net Income Avi to Common (ttm)-228.76M
Diluted EPS (ttm)-1.81
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)699.58M
Total Cash Per Share (mrq)4.94
Total Debt (mrq)54.69M
Total Debt/Equity (mrq)5.11
Current Ratio (mrq)13.06
Book Value Per Share (mrq)7.56

Cash Flow Statement

Operating Cash Flow (ttm)-123.61M
Levered Free Cash Flow (ttm)-109.33M